The Most Common Endocrine Disorder in Women
Polycystic ovary syndrome (PCOS) affects an estimated 8–13% of reproductive-age women, making it the most prevalent endocrine disorder in this population. Despite its frequency, PCOS is chronically underdiagnosed — studies suggest that up to 70% of affected women are undiagnosed — and frequently mismanaged when it is identified. Understanding PCOS from a hormonal perspective is essential for anyone involved in women’s health.
What Is PCOS?
PCOS is a complex hormonal disorder characterized by a cluster of three core features: androgen excess (elevated testosterone and other androgens), ovulatory dysfunction (irregular or absent ovulation), and polycystic ovarian morphology on ultrasound (enlarged ovaries with multiple small follicles). A diagnosis of PCOS requires at least two of these three criteria, per the widely used Rotterdam criteria.
The name “polycystic ovary syndrome” is somewhat misleading — the ovarian “cysts” are actually immature follicles that fail to develop and release eggs normally, and their presence on ultrasound is not required for diagnosis. Many women with PCOS do not have polycystic ovaries on imaging, while some women without PCOS do. The hormonal dysfunction is the defining characteristic.
The Hormonal Roots of PCOS
At its core, PCOS is a disorder of androgen excess and insulin resistance. Hyperinsulinemia — elevated insulin from insulin resistance — directly stimulates ovarian theca cells to overproduce androgens (primarily testosterone and androstenedione). Elevated LH (luteinizing hormone), which is characteristically elevated relative to FSH in classic PCOS, further amplifies ovarian androgen production. The resulting androgen excess disrupts normal follicle development, preventing ovulation and producing the characteristic cycle irregularity.
Insulin resistance is present in approximately 65–70% of women with PCOS — including lean women, not just those who are overweight. This is a critical point: PCOS is not simply a consequence of obesity. Lean women with PCOS have insulin resistance that is independent of body weight, driven by intrinsic metabolic dysfunction that may have genetic and epigenetic roots.
Symptoms and Manifestations
PCOS symptoms vary significantly between individuals — one of the reasons it’s so often misdiagnosed or diagnosed late. Common presentations include: irregular or absent menstrual periods (oligomenorrhea or amenorrhea), acne (particularly along the jawline and chin — a pattern associated with androgen excess), hirsutism (unwanted hair growth on the face, chest, abdomen, or back), scalp hair thinning or female-pattern hair loss, weight gain or difficulty losing weight, skin tags and acanthosis nigricans (dark velvety skin patches — markers of insulin resistance), infertility and miscarriage, mood disturbances including depression and anxiety, and fatigue.
Long-Term Health Risks
PCOS carries substantial long-term health implications beyond reproductive concerns. Women with PCOS have significantly increased risk of type 2 diabetes (up to 7-fold increased risk), metabolic syndrome, cardiovascular disease, non-alcoholic fatty liver disease, endometrial cancer (from chronic unopposed estrogen due to anovulation), and sleep apnea. These risks underscore the importance of addressing PCOS comprehensively — not just symptomatically.
Treatment Approaches
Effective PCOS management targets the underlying hormonal and metabolic drivers. Insulin sensitization — through lifestyle changes (diet, exercise, weight loss where appropriate) and/or metformin — is the foundational intervention for insulin-resistant PCOS, addressing the root cause rather than just symptoms. GLP-1 receptor agonists (semaglutide, tirzepatide) are emerging as highly effective options for PCOS, dramatically improving insulin sensitivity, reducing androgen excess, restoring ovulation, and supporting weight loss simultaneously.
Additional targeted therapies include inositol (particularly myo-inositol and D-chiro-inositol in 40:1 ratio), low-dose oral contraceptives for cycle regulation and androgen suppression, spironolactone for anti-androgen effects, and carefully managed progesterone therapy to protect the endometrium and support cycle regularity. An integrative approach addressing all dimensions of PCOS — metabolic, hormonal, and lifestyle — produces the best long-term outcomes.